Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited16.219619988134.6734
Domestic EquitiesDivi's Laboratories Limited5.96072206312.7424
Domestic EquitiesLupin Limited5.77816091012.3522
Domestic EquitiesSuven Pharmaceuticals Limited5.390210011111.5228
Domestic EquitiesApollo Hospitals Enterprise Limited5.15861666811.0279
Domestic EquitiesMax Healthcare Institute Limited5.06789876110.8336
Domestic EquitiesTorrent Pharmaceuticals Limited4.1097272178.7855
Domestic EquitiesAurobindo Pharma Limited3.6082664667.7134
Domestic EquitiesMankind Pharma Limited3.0879272246.6011
Domestic EquitiesAlkem Laboratories Limited2.8437124536.0792
Domestic EquitiesAster DM Healthcare Limited2.81501244626.0177
Domestic EquitiesAbbott India Limited2.428616905.1918
Domestic EquitiesNeuland Laboratories Limited2.278540354.8709
Domestic EquitiesGranules India Limited1.9941876504.2629
Domestic EquitiesDr. Reddy's Laboratories Limited1.9070356284.0766
Domestic EquitiesWockhardt Limited1.8957284514.0526
Domestic EquitiesHealthcare Global Enterprises Limited1.7221679123.6815
Domestic EquitiesSupriya Lifescience Limited1.7053496573.6456
Domestic EquitiesFortis Healthcare Limited1.5609477833.3369
Domestic EquitiesSumitomo Chemical India Limited1.5174579943.2439
Domestic EquitiesFDC Limited1.4357779083.0692
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.3916103282.9748
Domestic EquitiesRainbow Childrens Medicare Limited1.3212201502.8244
Domestic EquitiesOrchid Pharma Limited1.3163362582.8140
Domestic EquitiesCaplin Point Laboratories Limited1.2419132762.6549
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited1.2315162192.6327
Domestic EquitiesGland Pharma Limited1.2238164292.6162
Domestic EquitiesEmcure Pharmaceuticals Limited1.1700233232.5012
Domestic EquitiesSai Life Sciences Limited1.0589297512.2636
Domestic EquitiesVijaya Diagnostic Centre Limited1.0511223082.2469
Domestic EquitiesCipla Limited1.0402154192.2237
Domestic EquitiesOnesource Specialty Pharma Limited1.0268125272.1950
Domestic EquitiesShilpa Medicare Limited1.0242330042.1895
Domestic EquitiesSRF Limited0.983271512.1018
Domestic EquitiesUPL Limited0.9546320722.0406
Domestic EquitiesLinde India Limited0.917631351.9617
Domestic EquitiesSequent Scientific Limited0.91291491711.9515
Domestic EquitiesStrides Pharma Science Limited0.8619275331.8425
Domestic EquitiesLaurus Labs Limited0.7418258511.5857
Total 97.9543 209.4018
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)2.0457 4.3732
Total 2.0457 4.3732
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.